Detalhe da pesquisa
1.
Medication reuse programs: a narrative review of the literature.
Int J Qual Health Care
; 36(2)2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687831
2.
Implementation of Partnered Pharmacist Medication Charting in haematology and oncology inpatients.
J Oncol Pharm Pract
; : 10781552231180468, 2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37350675
3.
Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards.
Med J Aust
; 214(11): 528-531, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34053081
4.
Defibrotide for the treatment of sinusoidal obstruction syndrome: evaluation of response to therapy and patient outcomes.
Support Care Cancer
; 26(3): 947-955, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29022099
5.
Failure to achieve therapeutic levels with high-dose posaconazole tablets potentially due to enhanced clearance.
J Oncol Pharm Pract
; 24(1): 63-66, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27824587
6.
Dapsone and azole interactions: A clinical perspective.
J Oncol Pharm Pract
; 24(8): 637-640, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28732451
7.
Evaluation of NovoRapid infusion as a treatment option in the management of diabetic ketoacidosis.
Intern Med J
; 47(11): 1317-1320, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29105262
8.
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation.
Transfusion
; 55(11): 2709-13, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26173921
9.
Improving the transition of highly complex patients into the community: impact of a pharmacist in an allogeneic stem cell transplant (SCT) outpatient clinic.
Support Care Cancer
; 21(12): 3491-5, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23963769
10.
Incidence of Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease and Treatment with Defibrotide in Allogeneic Transplantation: A Multicenter Australasian Registry Study.
Transplant Cell Ther
; 29(6): 383.e1-383.e10, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36934993
11.
A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy.
Crit Rev Oncol Hematol
; 172: 103606, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101586
12.
Implementation of a pharmacist-initiated pharmaceutical handover for oncology and haematology patients being transferred to critical care units.
Support Care Cancer
; 18(7): 811-6, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19662439
13.
Dapsone for Pneumocystis jirovecii pneumonia prophylaxis - applying theory to clinical practice with a focus on drug interactions.
Drug Metab Pers Ther
; 35(3)2020 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32681773
14.
Validation of a risk stratification tool for a Hospital Outreach Medication Review (HOMR) program.
Res Social Adm Pharm
; 15(9): 1133-1137, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30279129
15.
Effectiveness of a single fixed dose of rasburicase 3 mg in the management of tumour lysis syndrome.
Br J Clin Pharmacol
; 75(2): 550-3, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22686734
16.
DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma.
Leuk Lymphoma
; 59(12): 2842-2846, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29616871
17.
Palifermin, administered for three doses only, reduces mucositis in patients undergoing HSCT and receiving chemoradiotherapy conditioning.
Bone Marrow Transplant
; 57(8): 1329-1331, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35589999
18.
Defibrotide for the management of sinusoidal obstruction syndrome in patients who undergo haemopoietic stem cell transplantation.
Cancer Treat Rev
; 50: 200-204, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27721142
19.
Isavuconazole as salvage therapy for mucormycosis.
Med Mycol Case Rep
; 11: 36-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158585
20.
Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.
Leuk Lymphoma
; 54(2): 336-41, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22812445